Yen-Lin Chen Selected Research

Chordoma

1/2023	The impact of radiotherapy on survival after surgical resection of chordoma with minimum five-year follow-up.
1/2017	Updated Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy.
12/2014	[18F]-Fluoromisonidazole positron emission tomography/computed tomography visualization of tumor hypoxia in patients with chordoma of the mobile and sacrococcygeal spine.
8/2014	Long-term results of Phase II study of high dose photon/proton radiotherapy in the management of spine chordomas, chondrosarcomas, and other sarcomas.
7/2013	Definitive high-dose photon/proton radiotherapy for unresected mobile spine and sacral chordomas.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yen-Lin Chen Research Topics

Disease

41	Neoplasms (Cancer) 05/2024 - 08/2006
23	Sarcoma (Soft Tissue Sarcoma) 04/2024 - 06/2010
13	Type 2 Diabetes Mellitus (MODY) 08/2023 - 05/2012
12	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2023 - 07/2011
10	Insulin Resistance 08/2023 - 06/2013
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 04/2014
8	Inflammation (Inflammations) 04/2024 - 01/2016
7	Hypertension (High Blood Pressure) 01/2024 - 11/2011
7	Osteosarcoma (Osteogenic Sarcoma) 10/2020 - 10/2011
7	Neoplasm Metastasis (Metastasis) 10/2020 - 08/2006
5	Lung Neoplasms (Lung Cancer) 05/2024 - 10/2017
5	Wounds and Injuries (Trauma) 04/2023 - 01/2018
5	Chordoma 01/2023 - 07/2013
4	Prostatic Neoplasms (Prostate Cancer) 12/2020 - 01/2012
4	Ewing Sarcoma (Sarcoma, Ewing) 01/2019 - 11/2009
3	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 08/2014
3	Adenocarcinoma 05/2024 - 04/2012
3	Rhabdomyosarcoma 11/2023 - 06/2015
3	Edema (Dropsy) 10/2023 - 01/2023
3	Mouth Neoplasms (Oral Cancer) 01/2023 - 01/2022
3	Chronic Disease (Chronic Diseases) 09/2022 - 01/2015
3	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 08/2014
3	Breast Neoplasms (Breast Cancer) 01/2020 - 02/2016
3	Hyperglycemia 01/2020 - 10/2017
2	Osteoarthritis 04/2024 - 09/2021
2	Carcinogenesis 11/2023 - 12/2018
2	Primary Graft Dysfunction 10/2023 - 05/2023
2	Reperfusion Injury 10/2023 - 05/2023
2	COVID-19 09/2023 - 04/2022
2	Hypoxia (Hypoxemia) 01/2023 - 12/2014
2	Sepsis (Septicemia) 01/2023 - 01/2021
2	Squamous Cell Carcinoma of Head and Neck 01/2023 - 01/2022
2	Pulmonary Hypertension 01/2023 - 01/2021
2	Tuberculosis (Tuberculoses) 12/2022 - 09/2022
2	Infections 12/2022 - 11/2019
2	Chondrosarcoma 09/2021 - 08/2014
2	Glioma (Gliomas) 01/2021 - 07/2019
2	Decompression Sickness (Bends) 12/2020 - 12/2018
2	Prediabetic State (Prediabetes) 03/2020 - 01/2016
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2020 - 10/2018
2	Chronic Kidney Failure (Chronic Renal Failure) 10/2019 - 07/2015
2	Leukemia 01/2019 - 01/2018
2	Margins of Excision 10/2016 - 08/2014
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2016 - 07/2013
2	Cachexia 01/2016 - 01/2015
2	Body Weight (Weight, Body) 01/2016 - 01/2015
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2016 - 01/2015
2	Atrophy 01/2016 - 01/2015

Drug/Important Bio-Agent (IBA)

17	Glucose (Dextrose)FDA LinkGeneric 08/2023 - 01/2013
12	Protons (Proton)IBA 04/2024 - 06/2010
11	Proteins (Proteins, Gene)FDA Link 04/2024 - 11/2007
4	Biomarkers (Surrogate Marker)IBA 09/2022 - 11/2011
4	CateninsIBA 04/2021 - 01/2013
4	Messenger RNA (mRNA)IBA 10/2020 - 03/2015
4	protein phosphatase 5IBA 12/2018 - 10/2017
4	ErbB Receptors (EGF Receptor)IBA 02/2015 - 04/2014
3	CytokinesIBA 04/2024 - 01/2021
3	pazopanib FDA Link 11/2023 - 01/2020
3	Therapeutic UsesIBA 09/2023 - 01/2020
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 08/2014
3	RNA (Ribonucleic Acid)IBA 12/2020 - 09/2013
3	Retinaldehyde (Retinal)IBA 01/2020 - 10/2018
3	Triglycerides (Triacylglycerol)IBA 11/2019 - 10/2012
3	Alanine Transaminase (SGPT)IBA 01/2018 - 07/2011
3	AMP-Activated Protein KinasesIBA 01/2018 - 10/2017
3	Uric Acid (Urate)IBA 01/2015 - 10/2012
2	Hematoxylin (Haematoxylon)IBA 05/2024 - 05/2009
2	Eosine Yellowish-(YS) (Eosin)IBA 05/2024 - 05/2009
2	Advanced Glycation End ProductsIBA 10/2023 - 10/2017
2	Glucagon-Like Peptide ReceptorsIBA 10/2023 - 10/2017
2	Purinergic P2Y2 ReceptorsIBA 10/2023 - 05/2023
2	VaccinesIBA 09/2023 - 04/2022
2	ChAdOx1 nCoV-19IBA 09/2023 - 04/2022
2	COVID-19 VaccinesIBA 09/2023 - 04/2022
2	ThalliumIBA 07/2022 - 02/2021
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2014
2	CCAAT-Enhancer-Binding Protein-deltaIBA 01/2021 - 07/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	MicroRNAs (MicroRNA)IBA 10/2020 - 09/2019
2	MucinsIBA 01/2020 - 04/2012
2	Endothelin-1 (Endothelin 1)IBA 01/2020 - 10/2018
2	Vasoconstrictor AgentsIBA 01/2019 - 10/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2019 - 01/2018
2	tissue-factor-pathway inhibitor 2 (PP5)IBA 12/2018 - 10/2017
2	EnzymesIBA 11/2018 - 05/2012
2	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 01/2017 - 05/2015
2	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2016 - 08/2014
2	Gemcitabine FDA Link 01/2016 - 01/2015
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 01/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2015 - 08/2006

Therapy/Procedure

32	Radiotherapy 01/2023 - 06/2010
17	Therapeutics 04/2023 - 08/2006
14	Drug Therapy (Chemotherapy) 11/2023 - 12/2014
8	Neoadjuvant Therapy 04/2023 - 11/2011
4	Proton Therapy 01/2017 - 11/2009
3	Aftercare (After-Treatment) 01/2016 - 11/2009
2	Lung Transplantation 10/2023 - 05/2023
2	Chemoradiotherapy 01/2023 - 01/2020
2	Renal Dialysis (Hemodialysis) 10/2019 - 01/2014